Advus Financial Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$449K Sell
1,065
-355
-25% -$141K 0.13% 93
2026
Q2
$514K Buy
+1,420
New +$486K 0.15% 89
2021
Q4
– Sell
-1,254
Closed -$282K – 51
2021
Q3
$282K Buy
+1,254
New +$289K 0.16% 78

Other funds holding AMGN

Advus Financial Partners's AMGN Position: Q3 2026 in Review

Advus Financial Partners reduced its Amgen (AMGN) stake by 25% in Q3 2026, selling an estimated $141K and leaving 1,065 shares worth $449K. The position accounts for 0.13% of the portfolio, ranked #93.

Advus Financial Partners first reported a position in AMGN in Q3 2021 and has held it in 3 quarters since. The position peaked at $514K in Q2 2026. 3,227 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Advus Financial Partners held 1,065 shares of Amgen worth $449K as of Q3 2026.
  • Advus Financial Partners sold 355 Amgen shares in Q3 2026, an estimated $141K.
  • Amgen made up 0.13% of Advus Financial Partners's portfolio in Q3 2026, its #93 holding.
  • Advus Financial Partners first reported a position in Amgen in Q3 2021 and has held it in 3 quarters since.
  • Advus Financial Partners's Amgen position peaked at $514K in Q2 2026.
  • 3,227 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Advus Financial Partners's 13F filing for Q3 2026, filed 20 Oct 2026.